{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:12:30Z","timestamp":1793967150947,"version":"4.8.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"41","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,6]]},"DOI":"10.1093\/eurheartj\/ehag656","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:15:10Z","timestamp":1786101310000},"page":"6180-6182","source":"Crossref","is-referenced-by-count":1,"title":["Even the most sophisticated cannot escape from the Reverend Bayes"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-3959","authenticated-orcid":false,"given":"Allan","family":"S. Jaffe","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN 55902 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026110518535152300_ehag656-B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41569-025-01211-5","article-title":"Takotsubo syndrome: pathophysiological insights and innovations in patient care","volume":"23","author":"Omerovic","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"2026110518535152300_ehag656-B2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/ejhf.683","article-title":"A novel clinical score (InterTAK diagnostic score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry","volume":"19","author":"Ghadri","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026110518535152300_ehag656-B3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cardfail.2013.12.004","article-title":"Diagnostic utility of cardiac biomarkers in discriminating takotsubo cardiomyopathy from acute myocardial infarction","volume":"20","author":"Randhawa","year":"2014","journal-title":"J Card Fail"},{"key":"2026110518535152300_ehag656-B4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.jacc.2022.08.767","article-title":"Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes","volume":"80","author":"Batra","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026110518535152300_ehag656-B5","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1093\/eurheartj\/ehag597","article-title":"Takotsubo syndrome diagnosis: the biomarker-based BioTAK score","volume":"47","author":"Wenzl","year":"2026","journal-title":"Eur Heart J"},{"key":"2026110518535152300_ehag656-B6","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","article-title":"Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur Heart J"},{"key":"2026110518535152300_ehag656-B7","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/eurheartj\/ehaf979","article-title":"JCAD predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk","volume":"47","author":"Kraler","year":"2026","journal-title":"Eur Heart J"},{"key":"2026110518535152300_ehag656-B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/eurheartj\/ehae602","article-title":"Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score","author":"Wenzl","year":"2024","journal-title":"Eur Heart J"},{"key":"2026110518535152300_ehag656-B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.113.004420","article-title":"Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in hospital revascularization: a substudy from the prospective randomized platelet inhibition and patient outcomes (PLATO) trial","volume":"129","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"2026110518535152300_ehag656-B10","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/41\/6180\/70840818\/ehag656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/41\/6180\/70840818\/ehag656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:58Z","timestamp":1793922838000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/41\/6180\/8772326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":10,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag656","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,1]]},"published":{"date-parts":[[2026,8,31]]}}}